Regional temperature profiles (rectal/sternal/nasal) during stop-flow perfusion with hemofiltration

Regional temperature profiles (rectal/sternal/nasal) during stop-flow perfusion with hemofiltration - Temperature study during stop-flow perfusion

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037596

Enrollment

Registered

2025-08-01

Start date

2025-06-12

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative hypothermia during stop-flow perfusion with hemofiltration

Interventions

Group 1: Temperature measurement during stop-flow chemotherapy without concomitant heat application (current standard treatment protocol. Group 2: Temperature monitoring during stop-flow chemotherapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: stop-flow perfusion chemotherapy / regional chemotherapy

Exclusion criteria

Exclusion criteria: Procedural sedation and analgesia

Design outcomes

Primary

Measure	Time frame
Difference in mean intraoperative body temperature between the two groups.	—

Secondary

Measure	Time frame
Incidence and duration of significant intraoperative hypothermia (<35 °C) Maximum and minimum regional temperatures (rectal, presternal, nasal) Duration within the tolerable core temperature range (35.5–37.5 °C) Correlation between temperature trends and vital signs (e.g., hemodynamic stability, heart rate, blood pressure) Postoperative temperature progression (optional)	—

Countries

Germany

Contacts

Public ContactHansjörg Aust

Medias Klinikum GmbH & Co KG

h.aust@medias-klinikum.de+49 (0) 867791 60407

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026